alexa The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma.
Molecular Biology

Molecular Biology

Journal of Cytology & Histology

Author(s): Johnstone S, Logan RM

Abstract Share this page

Abstract A better understanding of oral cancer pathogenesis is essential to improving patient prognosis and treatment modalities. Research has shown a significant increase in vascularity during the transition from normal oral mucosa, through differing degrees of dysplasia, to invasive carcinoma. A close association between tumour angiogenesis and tumour progression to late oral squamous cell carcinoma has also been reported. Vascular endothelial growth factor (VEGF) acts to induce endothelial proliferation, migration and specialisation in new and developing vascular beds. VEGF is also a promoter of angiogenesis in many tumour types, and has therefore been subject to numerous studies in oral dysplasia and squamous cell carcinomas. The contribution of VEGF to the development of oral dysplasia and invasive carcinomas is currently disputed due to conflicting results within the literature. More research is required before VEGF technology can be used to improve the diagnosis, prognosis and treatment of sufferers. This article was published in Oral Oncol and referenced in Journal of Cytology & Histology

Relevant Expert PPTs

Relevant Speaker PPTs

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version